DILGER Andrew K.,DILGER Andrew K.,CORTE James R.,CORTE James R.,DE LUCCA Indawati,DE LUCCA Indawati,FANG Tianan,FANG Tianan,YANG Wu,YANG Wu,WANG Yufeng,WANG Yufeng,PABBISETTY Kumar Balashanmuga,PABBIS
申请号：
SI201530121
公开号：
SI3099688T1
申请日:
2015.01.30
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
